Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease

Journal: Journal of Clinical Investigation

Published: 2020-01-02

DOI: 10.1172/jci131116

Affiliations: 23

Authors: 54

Go to article
Institutions Share
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA) 0.30
NIH NIAID Division of Intramural Research (DIR), United States of America (USA) 0.16
NIH NCI Center for Cancer Research (CCR), United States of America (USA) 0.11
University of Antioquia (UdeA), Colombia 0.07
NIH National Human Genome Research Institute (NHGRI), United States of America (USA) 0.06
Erciyes University, Turkey 0.06
Texas Children's Hospital, BCM, United States of America (USA) 0.04
Max Planck Institute of Biochemistry, Germany 0.04
Boston University (BU), United States of America (USA) 0.04
NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), United States of America (USA) 0.04
NIH Center for Human Immunology (CHI), United States of America (USA) 0.02
Mayo Clinic, United States of America (USA) 0.02
NIH Clinical Center, United States of America (USA) 0.02
NIH National Cancer Institute (NCI), United States of America (USA) 0.01
Shenzhen Children's Hospital, China 0.01
Carolinas Medical Center (CMC), Atrium Health, United States of America (USA) 0.01
Levine Children's Hospital, Atrium Health, United States of America (USA) 0.01
NIH National Institute of Neurological Disorders and Stroke (NINDS), United States of America (USA) 0.01

Return